Bellicum To Present At The Ladenburg Thalmann 2016 Healthcare Conference

HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that Tom Farrell, President and CEO, will present at the Ladenburg Thalmann 2016 Healthcare Conference. The presentation will take place on Tuesday, September 27, 2016 at 10:00 a.m. EDT in New York City.